AutoPELSA: an automated sample preparation system for proteome-wide identification of target proteins of diverse ligands

Lianji Xue, Xi Wang, Hui Yang, Jiahua Zhou, Haiyang Zhu, Jinhua Shen, Weina Gao, Ruijun Tian, Yuyi Wang, Mingliang YebioRxiv 2026 · DOI

TL;DR

Researchers have developed AutoPELSA, an automated system that significantly speeds up and improves the reliability of a powerful technique (PELSA) for identifying how proteins interact with small molecules. This new platform enables high-throughput, large-scale analysis of these crucial interactions, paving the way for faster drug discovery and a deeper understanding of cellular processes.

What Problem Does This Paper Address?

Understanding how proteins interact with small molecules (ligands) is fundamental to many biological processes and is a cornerstone of drug discovery. The peptide-centric local stability assay (PELSA) is a highly sensitive method for identifying these interactions and pinpointing where on the protein the binding occurs. However, the manual PELSA workflow is notoriously time-consuming and labor-intensive, involving numerous steps that introduce variability and limit the number of samples that can be processed. This bottleneck severely restricts its application for large-scale studies, such as screening many potential drug candidates or comprehensively mapping interactions within a cell. The authors aim to overcome these limitations by automating the entire PELSA process.

Methods

The core innovation is the development of AutoPELSA, an automated platform that streamlines the PELSA workflow. It consists of two main modules:

  1. Automated Limited Trypsinization: This module uses a liquid-handling workstation with a 96-channel pipette to perform ligand incubation, precisely timed trypsin digestion, protein denaturation, reduction, alkylation, and final acidification. The key here is the precise control over the short digestion times, which is critical for PELSA's sensitivity. They also optimized acid quenching with HCl as a rapid and effective method to stop the trypsin activity, which is more amenable to automation than the traditional guanidine hydrochloride method.
  2. High-Throughput Cleanup with a Multilayer Tip-Column: After digestion, the sample contains peptides, protein fragments, and residual trypsin. To prepare for mass spectrometry (MS), these need to be removed and the peptides desalted. AutoPELSA consolidates these steps into a single operation using a custom C4-SCX-C18 multilayer tip. This tip sequentially uses different sorbent materials (C4 for hydrophobic interactions, SCX for ion exchange, and C18 for reversed-phase) to capture and separate proteins and peptides, while also desalinating the sample. This replaces multiple manual steps like ultrafiltration and solid-phase extraction, significantly reducing hands-on time and improving throughput.

Datasets

The study uses K562 cell lysates as the biological sample. They also use known ligands such as staurosporine (a kinase inhibitor) and α-ketoglutarate (a metabolite) to validate the system's performance. No new benchmark datasets were introduced; rather, the performance of AutoPELSA is compared against the established manual PELSA protocol and other orthogonal methods.

Key Insights and Ideas

  • Automation is Key to Scalability: The most significant insight is that automating the PELSA workflow is essential for making it a practical tool for large-scale studies. The manual process's inherent variability and time demands are major roadblocks that AutoPELSA effectively removes.
  • Multilayer Tip Design is a Game Changer: The innovative C4-SCX-C18 multilayer tip is a crucial component. It elegantly combines protein removal, desalting, and peptide enrichment into a single, automated step, drastically reducing sample preparation time and complexity.
  • Precision in Automation: The ability to precisely control short incubation and digestion times, which is difficult with manual handling, is critical for PELSA's sensitivity. AutoPELSA achieves this through automated liquid handling.
  • Low-Affinity Interactions are Detectable: AutoPELSA not only identifies strong interactions but also reliably detects targets of low-affinity ligands, expanding the scope of PELSA applications.
  • Multiplexed Affinity Profiling: The development of a mixed-ligand dose-response strategy allows for simultaneous profiling of multiple ligands and their binding affinities in a single experiment, a significant advancement for screening and drug discovery.

Key Results

  • Throughput Increase: AutoPELSA achieves a substantial throughput increase of approximately ~20-fold, processing 96 samples in about 4 hours, compared to the manual workflow which takes ~18 hours for just 8 samples.
  • Improved Precision and Reproducibility: AutoPELSA demonstrated improved precision, with a median coefficient of variation (CV) of 18.2% compared to 24.0% for manual PELSA. It also showed higher between-replicate concordance and high intra- and inter-batch reproducibility.
  • Identification of Targets:
    • For staurosporine, AutoPELSA identified 114 kinase targets, an increase compared to the manual PELSA (101 targets).
  • For α-ketoglutarate, AutoPELSA identified 41 significantly ligand-stabilized proteins at 2 mM and 424 at 10 mM, including 30 known targets at the lower concentration.
  • Accurate Affinity Measurement: The EC50 values derived from AutoPELSA showed strong agreement with orthogonal affinity measurement approaches, validating its capability for quantitative affinity profiling.
  • Region-Specific Resolution: The system can resolve interactions at the domain level, demonstrating that stabilization is localized to annotated binding domains.

Limitations and Future Work

  • Limitations: While AutoPELSA significantly improves throughput and reproducibility, the paper does not explicitly detail limitations of the automated system itself beyond the inherent challenges of the PELSA method. The comparison with kinobeads assays suggests that kinobeads might identify more targets, but this is attributed to the broader scope of the kinobeads data (multiple cell lines and experimental replicates) rather than a limitation of AutoPELSA's accuracy within a single-cell-line context.
  • Future Work: The authors suggest that AutoPELSA provides a scalable and modification-free platform for proteome-wide interrogation of ligand-protein interactions. The ability to perform multiplexed affinity profiling and resolve interactions at the domain level opens doors for systematic mapping of ligand-target landscapes, guiding rational drug development, and deciphering mechanisms of action for drug candidates. Further applications in complex biological matrices and with a wider range of ligand types are implied.

Summary updated

Abstract

Abstract Protein-ligand interactions are fundamental to cellular function and drug discovery, and ligand-modification-free strategies have emerged as powerful tools for proteome-wide interrogation of these interactions. Among these, the peptide-centric local stability assay (PELSA) stands out for its high sensitivity. It uses a single digestion step to detect ligand-induced local stability shifts, enabling precise binding region localization and affinity estimation. However, manual PELSA workflows suffer from multiple labor-intensive steps that introduce variability and constrain throughput, limiting large-scale applications. To address these limitations, we developed AutoPELSA, an automated platform that streamlines the PELSA workflow including the limited proteolysis step and the following peptide separation step. AutoPELSA completes 96 samples in ∼4 h, enabling high-throughput analysis under native conditions. AutoPELSA reliably detected targets of both strong-affinity ligands (e.g., staurosporine, identifying 114 kinase targets) and low-affinity ligands, including α-ketoglutarate (30 known targets). Furthermore, a mixed-ligand dose–response strategy enabled simultaneous determination of binding affinities for multiple ligand–protein interaction regions in a single experiment. Overall, AutoPELSA provides a scalable and modification-free platform for proteome-wide identification and affinity profiling of ligand–protein interactions.
BibTeX
@misc{xue2026autopelsa,
  author = {Lianji Xue and Xi Wang and Hui Yang and Jiahua Zhou and Haiyang Zhu and Jinhua Shen and Weina Gao and Ruijun Tian and Yuyi Wang and Mingliang Ye},
  title = {{AutoPELSA: an automated sample preparation system for proteome-wide identification of target proteins of diverse ligands}},
  year = {2026},
  doi = {10.64898/2026.01.08.697612},
  howpublished = {bioRxiv},
}
Figure